DEFA14A: Corvus Pharmaceuticals Sets Date for 2025 Annual Stockholder Meeting

Corvus Pharmaceuticals will hold its 2025 Annual Meeting of Stockholders virtually on June 12, 2025, to vote on director elections, auditor ratification, and executive compensation.

Summary

• Corvus Pharmaceuticals has scheduled its 2025 Annual Meeting of Stockholders for June 12, 2025, at 1:00 p.m. Pacific Time.
• The meeting will be held virtually via the internet at meetnow.global/MPVXYD4.
• Stockholders will vote on three proposals: electing two Class III Directors, ratifying PricewaterhouseCoopers LLP as the independent auditor, and approving executive compensation on an advisory basis.
• The Board of Directors recommends voting FOR the election of director nominees and FOR Proposals 2 and 3.
• Proxy materials, including the 2025 Proxy Statement and Annual Report on Form 10-K, are available online at www.envisionreports.com/CRVS.
• Stockholders can request a paper copy of the proxy materials by May 30, 2025.
• To access the virtual meeting, stockholders will need the information printed in the shaded bar on the reverse side of the notice.

Sentiment

Score: 7

Explanation: The document is a neutral announcement regarding the annual stockholder meeting, with a focus on procedural matters and voting recommendations. It doesn't contain any particularly positive or negative information, hence the neutral sentiment.

Positives

• The meeting is being held virtually, providing convenient access for stockholders.
• Stockholders have multiple options for accessing proxy materials and voting, including online, phone, and email.
• The Board of Directors is providing clear recommendations on how to vote on each proposal.

Future Outlook

The document outlines the agenda and process for the upcoming annual meeting, focusing on corporate governance matters.

Industry Context

This announcement is a standard part of corporate governance, ensuring shareholders have the opportunity to participate in key decisions regarding the company's direction and oversight.

Stakeholder Impact

• Shareholders are encouraged to participate in the voting process to influence the company's governance.
• The outcome of the votes will impact the composition of the Board of Directors and the selection of the independent auditor.

Next Steps

• Stockholders should review the proxy materials.
• Stockholders should vote on the proposals before the meeting.
• Stockholders can attend the virtual meeting on June 12, 2025.

Key Dates

Keywords

Annual Meeting, Stockholders, Proxy Statement, Corvus Pharmaceuticals, Voting, Directors, Auditor, Executive Compensation